Environmental Factors Related to Acute Rheumatic Fever and Rheumatic Heart Disease in Aceh Province
Abstract
Acute rheumatic fever (ARF) is the body’s immune system reacting to an untreated infection with Group A Streptococcus (GAS) that affects skin, joints, brain, and heart. The heart damage that remains after an occurrence of ARF is called rheumatic heart disease (RHD). The objective of this study was to evaluate the ARF and RHD based on the profile of clinical diagnoses and emerging factors. The data were collected through interviews of the subjects, complete blood counts, the anti-streptolysin titer O analysis, the C-reactive protein Assay, and a statistical analysis. This research was a combination of clinical assessments, the CRP kit, anti-titer O kit, and interviews. The data were analyzed by employing Wilcoxon, Chi-square and Friedman test and also included a correlation analyzed using Spearman’s correlation with significance of (p<0.05. There were 63 samples of ARF and RHD patients involved, consisting of male (50.8%:32) and female (49.9%:31) patients (p<0.05). The factors that triggered ARF and RHD (p<0.05; r=0.88) as well as laboratory diagnosis (p<0.05) of these infections were measured. The ARF caused by residence also caused RHD by the interaction of time with the environment (p<0.05). The population consisted of males (32:50.8%) and females (31:49.2%), and it was not significant (p>0.05), while the streptococcal infection of RHD (63.5%) was much larger than in ARF (36.5%). This was based on the clinical diagnosis of RHD and ARF with a significance of (p<0.05). Also, the residence and the period of interaction with the environment were influences on the RHD and ARF.
Keywords
Full Text:
PDFReferences
Beg, A, Younas M. Rheumatic heart disease (RHD); Socio-economic and environment risk factors for acut rheumatic fever (ARF) and rheumatic heart disease (RHD) patients in Pakistan. Professional Med J 2016;23:324-327.
Boon NA, Bloomfield P. The medical management of valvar heart disease. Heart 2002;87:395-400.
Carapetis JR, Beaton A, Cunningham MW, et al. Acute rheumatic fever and rheumatic heart disease. Nat Rev Dis Primers 2016;2:15084.
Carapetis JR. Rheumatic heart disease in developing countries. N Engl J Med 2007;357:439-441
Cengel-Kültür SE, Cöp E, Kara A, Cengiz AB, Uludağ AK, Unal F. The relationship between group A beta hemolytic streptococcal infection and psychiatric symptoms: a pilot study. Turk J Pediatr. 2009;51:317-324.
Coffey PM, Ralph AP, Krause VL. The role of social determinants of health in the risk and prevention of group A streptococcal infection, acute rheumatic fever and rheumatic heart disease: A systematic review. PLoS Negl Trop Dis 2018;12:e0006577.
Fieber C, Kovarik P. Responses of innate immune cells to group A Streptococcus. Front Cell Infect Microbiol 2014;4:140.
Gewitz MH, Baltimore RS, Tani LY, et al. Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation 2015;131:1806-1818.
Hu W, Ye Y, Yin Y, et al. Association of matrix metalloprotease 1, 3, and 12 polymorphisms with rheumatic heart disease in a Chinese Han population. BMC Med Genet 2018;19:27.
Jaine R, Baker M, Venugopal K. Acute rheumatic fever associated with household crowding in a developed country. Pediatr Infect Dis J 2011;30: 315-319.
Julius WD. Rheumatic heart disease. J Medula 2016;4:138-144.
Kamel H, Bartz TM, Longstreth WT, et al. Association between left atrial abnormality on ECG and vascular brain injury on MRI in the Cardiovascular Health Study. Stroke 2015;46:711-716.
Kotby AA, Habeeb NM, Ezz El Elarab S. Antistreptolysin O titer in health and disease: levels and significance. Pediatr Rep 2012;4:e8.
Maganti K, Rigolin VH, Sarano ME, Bonow RO. Valvular heart disease: diagnosis and management. Mayo Clin Proc 2010;85:483-500.
Minodier P, Laporte R, Miramont S. Epidemiology of Streptococcus pyogenes infections in developing countries. Arch Pediatr 2014;21(Suppl 2):S69-S72
Mishra T. Acute rheumatic fever and rheumatic heart disease: current scenario. J Indian Acad Clin Med 2007;8: 324-330.
Nkomo VT. Epidemiology and prevention of valvular heart diseases and infective endocarditis in Africa. Heart 2007;93:1510–1519.
Oliver SJ, Cush J, Ward JE. Community-Based Prescribing for Impetigo in Remote Australia: An Opportunity for Antimicrobial Stewardship. Front Public Health 2017;5:158.
Ozer S, Hallioğlu O, Ozkutlu S, Celiker A, Alehan D, Karagöz T. Childhood acute rheumatic fever in Ankara, Turkey. Turk J Pediatr. 2005 Apr-Jun;47:120-124.
Rothenbühler M, O'Sullivan C, Stortecky S, et al. Active surveillance for rheumatic heart disease in endemic regions: a systematic review and meta-analysis of prevalence among children and adolescents. Lancet Glob Health 2014;2:e717-e726.
Rodriguez-Fernandez R, Amiya R, Widdodow W, Carapetis J. Rheumatic heart disease among adults in a mining community of Papua, Indonesia: findings from an occupational cohort. Heart Asia 2015;7:1-5.
Roberts K, Cannon J, Atkinson D, Brown A, Maguire G, Remenyi B. Echocardiographic Screening for Rheumatic Heart Disease in Indigenous Australian Children: A Cost-Utility Analysis. J Am Heart Assoc. 2017;6:e004515.
Reményi B, Wilson N, Steer A, Ferreira B, Kado J, Kumar K. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease--an evidence-based guideline. Nat rev. Cardiol 2012;9297-9309.
Seckeler MD, Hoke TR. The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol 2011;3:67-84.
Steger CM. Rheumatic heart disease. BMJ Case Rep. 2015;2015:bcr2015211943.
Shulman ST, Tanz RR. Group A streptococcal pharyngitis and immune-mediated complications: from diagnosis to management. Expert Rev Anti Infect Ther 2010;8:137-150.
Steer AC, Carapetis JR, Nolan TM, Shann F. Systematic review of rheumatic heart disease prevalence in children in developing countries: the role of environmental factors. J Paediatr Child H 2002;38:229-234.
Süleymanoğlu S, Okutan V, Yozgat Y, Lenk MK. Determination of normal echocardiographic values for right ventricular volume in children with two-dimensional transthoracic echocardiography. Turk J Pediatr. 2007;49:141-147.
Tandon R, Sharma M, Chandrashekhar Y, Kotb M, Yacoub MH, Narula J. Revisiting the pathogenesis of rheumatic fever and carditis. Nat Rev Cardiol 2013;10(3):171-177.
Tang JW, Li Y, Eames I, Chan PK, Ridgway GL. Factors involved in the aerosol transmission of infection and control of ventilation in healthcare premises. J Hosp Infec 2006;64:100-114.
Watkins DA, Johnson CO, Colquhoun SM, et al. Global, regional, and national burden of rheumatic heart disease, 1990–2015. N Eng J Med 2017;377:713-722.
Walker MJ, Barnett TC, McArthur JD, et al. Disease manifestations and pathogenic mechanisms of Group A Streptococcus. Clin Microbiol Rev 2014;27:264-301.
Yancy CW, Jessup M, Bozkurt B, et al. ACCF/AHA Guideline for the Management of Heart Failure. J Am Coll Cardiol. 2013;62:e147-e239.
Zhang P, Bao Y, Draz MS, Lu H, Liu C, Han H. Rapid and quantitative detection of C-reactive protein based on quantum dots and immunofiltration assay. Int J Nanomedicine. 2015;10:6161–6173.
DOI: https://doi.org/10.33258/birex.v2i2.1004
Article Metrics
Abstract view : 437 timesPDF - 224 times
Refbacks
- There are currently no refbacks.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.